Founded by a research team composed of postdoctoral fellows and scientists from multiple prestigious universities and institutions in the United States in 2014. We has been dedicating to the innovation of cell morphology technology and developed IVD medical devices combines machine vision and AI to protect and support people’s health through accurate, fast and stable diagnostic testing.
Our technology and services are used by over 35,000 medical institutions all over the world with our passionate and dedicated team from diverse cultures. We aimed to change and improve the method and efficiency through innovative technologies to reshaping diagnostics for everyone at everywhere with high quality medical services.
Founded by a research team composed of postdoctoral fellows and scientists from multiple prestigious universities and institutions in the United States, including Lawrence Berkeley National Laboratory, California Department of Public Health, McMaster University and U.S. National Academy of Sciences in 2014.
We has been dedicating to the innovation of cell morphology technology and developed IVD medical devices combines machine vision and AI to protect and support people’s health through accurate, fast and stable diagnostic testing.
Our technology and services are used by over 35,000 medical institutions all over the world.
By introducing innovative products (such as new medical instruments and technologies) to change and improve diagnostic methods and efficiency, thereby 'reshaping diagnostics.' These products may include innovative diagnostic devices, portable testing tools, and more controllable consumables.
By introducing innovative products (such as new medical instruments and technologies) to change and improve diagnostic methods and efficiency, thereby 'reshaping diagnostics.' These products may include innovative diagnostic devices, portable testing tools, and more controllable consumables.
Providing more contextualized services to achieve a healthy lifestyle, including customer support, technical maintenance, and data analysis services. These services are designed to ensure the optimal functioning of equipment, guaranteeing that patients receive continuous health management and monitoring, thus supporting and promoting a healthy lifestyle.
We are dedicated to developing and applying the most advanced cell testing technologies,providing medical professionals with portable blood diagnostic devices that are more accurate and accessible anywhere.
We are a team passionate about work and dedicated to technology innovation. We encourage our people to initiate new ideas and solutions, constantly seeking improvement and innovation. To unleash the power and potential of every one of us, we keep learning new skills and knowledge.
Our dedication to work is reflected in our continuous pursuit of excellence in technology, quality and service. We are always customer oriented and offering solutions to meet clinical requirements.
Reshaping Diagnostics for everyone everywhere changing and improving the method and efficiency through innovative technologies to reshaping diagnostics for everyone at everywhere with high quality medical services.
Reshaping Diagnostics for everyone everywhere changing and improving the method and efficiency through innovative technologies to reshaping diagnostics for everyone at everywhere with high quality medical services.
Our history traced back to 2014, when a research team composed of postdoctoral fellows and scientists from multiple prestigious universities and institutions in the United States, including two postdoctoral fellows from the Lawrence Berkeley National Laboratory, a postdoctoral fellow from the California Department of Public Health, a professor from McMaster University, as well as Dr. Joshua Robinson and Academician Hongjie Dai from the U.S. National Academy of Sciences, was established in Joinn Innovation Park, located in the heart of Silicon Valley, California, USA. In the same year of November, we had research cooperation with Nirmidas and StartX (Stanford’s Accelerator) on Personal and Portable Health Diagnostic Testing. In the following year, our first colloidal analyzer passed the test from DCN, the authorized device test organization in the US.
Our research and development continued in the next few years with encouraging results by steady progress. In 2016, we developed colloidal gold test strip product antibodies in collaboration with ProMab and 2 patents obtained in the same year. In the next 3 years, we updated the version each year from Colloidal analyzer 2.0 version, Second Generation of colloidal analyzer: EHB-2.3 to version EHB3.0-EBH3.1.
When the COVID pandemic prevailed in 2020, our core team decided to move back to Germany. The R&D continued until our first hematology analyzer based on cell morphology technology came alive in 2021. Our brand story started by then...